References in periodicals archive ?
BELIEVE is the first trial to examine this process with advanced imaging and a standardized approach to anticoagulation in patients undergoing implantation of LivaNova bioprosthetic aortic valves.
This procedure is a minimally invasive procedure that allows the cardiologist to cure a severely narrowed aortic valve without opening up the patient's chest by replacing the valve without removing the old, damaged valve.
Various hypothesis has been proposed to explain the association of aortic valve prolapse but most commonly accepted mechanism is Venturi effect.
Bicuspid aortic valve (BAV) is the most common congenital cardiac malformation affecting 1% to 2% of the general population.
The risk of aortic stenosis rises not only with age but also in people with congenital defects, such as a bicuspid aortic valve (which has two leaflets instead of three), or those with scarring from rheumatic fever.
New re-constructive surgical approaches for aortic valve repair are currently being studied.
The patient had severe calcification of his aortic valve, which caused it to narrow with inefficiency of blood flow to the valve of the fourth-degree.
As described in a prior edition of this newsletter, transcatheter aortic valve replacement (TAVR) is an innovative and revolutionary treatment for patients with aortic valve stenosis.
The transcatheter aortic valve replacement (TAVR) or transcatheter aortic valve implantation (TAVI) operations are the first ever in Bahrain.
The company is taking on the big boys in what's becoming an increasingly competitive transcatheter aortic valve implantation (TAVI) sector.